Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors.
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors. Mol Cancer. 2010 Jun 04; 9:138.
View in:
PubMed
subject areas
Angiogenesis Inhibitors
Animals
Antineoplastic Agents
Cell Line, Tumor
Cell Movement
Disease Progression
Endothelial Cells
Fluorescent Antibody Technique
Humans
Mice
Mice, Nude
Neovascularization, Pathologic
Neuroblastoma
Osteonectin
Peptides
Xenograft Model Antitumor Assays
authors with profiles
Alexandre Chlenski
Radhika R. Peddinti